AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug
Summary
AbbVie Inc. shares are down during Friday’s premarket session following a Complete Response Letter (CRL) from the FDA regarding the Biologics License Applicat...
Description
AbbVie Inc. shares are down during Friday’s premarket session following a Complete Response Letter (CRL) from the FDA regarding the Biologics License Applicat...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source